Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sabrina Sahni
Observed names:
S. Sahni,
Sabrina K Sahni,
Sabrina K. Sahni,
Sabrina Kaur Sahni
Institution:
Mayo Clinic in Florida
Observed institutions:
Cleveland Clinic,
Cleveland Clinic Florida,
Mayo Clinic in Florida,
Mayo Clinic Comprehensive Cancer Center (Florida)
OpenAlex ID:
A5042919569
Contemporary Non-hormonal Therapies for the Management of Vasomotor Symptoms Associated with Menopause: A Literature Review
2021
·
Sabrina Sahni
, Angie Lobo-Romero
, et al.
·
touchREVIEWS in Endocrinology
·
23
PDF
Postmenopausal Hormone Therapy—Local and Systemic: A Pharmacologic Perspective
2020
·
Taryn Smith
, Sabrina Sahni
, et al.
·
The Journal of Clinical Pharmacology
·
21
Prevalence, Impact, and Diagnostic Challenges of Benign Breast Disease: A Narrative Review
2023
·
Jessica L Fraker
, Caroline G Clune
, et al.
·
International Journal of Women s Health
·
12
PDF
Menopausal Hormone Therapy in Older Women: Examining the Current Balance of Evidence
2023
·
Paru S. David
, Talia Sobel
, et al.
·
Drugs & Aging
·
7
Women’s health 2019: Osteoporosis, breast cancer, contraception, and hormone therapy
2019
·
Anna Camille Moreno
, Sabrina Kaur Sahni
, et al.
·
Cleveland Clinic Journal of Medicine
·
6
Hormone therapy in women with benign breast disease – What little is known and suggestions for clinical implementation
2024
·
Sabrina K. Sahni
, Jessica L. Fraker
, et al.
·
Maturitas
·
1
Breast cancer risk in peri- and postmenopausal women with a history of hormonal contraceptive use: A narrative review
2026
·
Dewonna Ferguson
, Jessica Fraker
, et al.
·
Maturitas
Abstract PD4-04: Impact of Polygenic Risk Scores on Breast Cancer Risk Assessment and Clinical Decision Making in Carriers of Germline Pathogenic Variants in ATM, BRCA1, BRCA2, CHEK2, and PALB2: Results from the Prospective Multisite GENRE-2 Clinical Trial
2026
·
S. Yadav
, C. Klassen
, et al.
·
Clinical Cancer Research
Mo1347 PHASE II TRIAL OF RIFAXIMIN IN PATIENTS WITH EARLY-STAGE HER2 POSITIVE BREAST CANCER WITH GASTROINTESTINAL TOXICITIES RELATED TO PERTUZUMAB-BASED THERAPY
2024
·
Maria Vazquez Roque
, Stephen Johnson
, et al.
·
Gastroenterology
Management of a Woman at Elevated Risk for Breast Cancer
2021
·
Sabrina K. Sahni
, Nidhi Sharma
, et al.
·
Springer eBooks
Show more works
View as search
Works count:
10
Citation count:
70
H-index:
5
I10-index:
3
Year
Topic
Type